Insights into metabolic dysregulations associated with antipsychotics

Lancet Psychiatry. 2020 Jan;7(1):6-7. doi: 10.1016/S2215-0366(19)30473-0. Epub 2019 Dec 17.

Authors

Yoav Domany¹, Mark Weiser²

Affiliations

¹ Department of Psychiatry, Sheba Medical Center, Ramat Gan 52621, Israel; Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
² Department of Psychiatry, Sheba Medical Center, Ramat Gan 52621, Israel; Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel. Electronic address: mweiser@netvision.net.il.

PMID: 31860456
DOI: 10.1016/S2215-0366(19)30473-0

No abstract available

Publication types

Comment

MeSH terms

Antipsychotic Agents*
Humans
Network Meta-Analysis
Schizophrenia*
Weight Gain / drug effects

Substances

Antipsychotic Agents